Dr. Ron Cohen sits down with President Bill Clinton for a powerful conversation on the impact of the Human Genome Project, the personalized medicine revolution, and the birth of pharmacogenomics.

Watch Ken Keller, Tom Pike and Matt Wallach talk cold, hard truths of what it means to be a sales reps in pharma.

US Congressman and Former Chairman of the Committee on Energy and Commerce, Fred Upton, speaks to the importance of the 21st Century Cures Act.

President Bill Clinton talks about the challenges and opportunities provided by exponential growth. President Clinton also includes insights and key learnings from initiatives launched by The Clinton Foundation.

Ryan Olohan wants you to ask yourself: are you aiming high enough? Are you thinking big enough?

Dr. Francis Collins shares his thoughts on the 21st Century Cures Act and a includes a personal message to the people behind it.

Dr. Peggy Hamburg brings her perspective and personal insights to the 21st Century Cures Act.

Jay Goldman sits down with Halle Tecco, Asaf Evenhaim, and Greg Szwartz to explore how companies navigate periods of hypergrowth without compromising their mission.

Dr. Bob Hariri shares his expertise on stem cells, the perfect repair kit.

Dr. Ron Cohen sits down with Dr. George Yancopoulos, Dr. David Ledbetter, and Dr. Katrine Bosley to explore real life scenarios of genome mining and editing, including ethical issues they may face.

Dr. Daniel Kraft joins forces with pharma tycoons - Dr. Martine Rothblatt, R.J. Kirk, and Dr. Bob Hariri, to talk current projects, and what they can bring to the future of medicine.

Leerom Segal speaks to exponential advances in technology and medicine.

Some of the most vexing challenges in healthcare involve connecting genuinely with the patient. Watch Matthew Zachary, Jack Barrette, Christine Miserandino, David Fuehrer, Jane Sarasohn-Kahn, and Adrianne Haslet-Davis share their personal patient journey.

Roger Longman explores health policy and innovation with Dr. Michael Sherman, Dr. Steve Miller, and Dr. Peter Bach.

Eythor Bender speaks to bionic and orthopedic technology, and his innovations.

Dr. Janet Woodcock sits down with Jim Greenwood to share her thoughts on the 21st Century Cures initiative, how to improve clinical trials, and how to incorporate the patient's' perspective into drug development and healthcare.

Dr. Eric Topol talks about telemedicine and healthcare on demand, and apps that will summon physicians to your home.

Gary Hamel details how bureausclerosis can cause systemic challenges in almost any organization.

Dr. Ezekiel Emanuel on the burden and opportunity cost of specialty drugs on the average American family.

Tom Peters delves into leadership in healthcare companies and the vital skills top leaders should hone in order to succeed.